Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- befree-2016 importedOn "2016-02-19" NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion wasGeneratedBy ECO_0000203 NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion wasDerivedFrom befree-2016 NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion SIO_000772 8027338 NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion evidence source_evidence_literature NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.
- NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_assertion description "[Examination of sera from patients with Lyme disease revealed that antibodies to P22 are rarely detected in patients with early-stage disease characterized by erythema migrans (2 of 20), and 35% of the patients with late-stage disease characterized by arthritis (9 of 26) developed antibodies to P22.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330229.RA2amJ0A-o-PQFhOQ0j_m9pOpkPzNFuTHB6216Wm4c5TA130_provenance.